---
category: trading
circular_id: 19ae611ee6f9363d
date: '2026-01-14'
description: BSE extends bid end date for SHENTRACON CHEMICALS LIMITED acquisition
  window from January 23, 2026 to January 27, 2026 with revised settlement dates in
  February 2026.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={34C3BBE2-5F53-43FD-BB76-C4C5FD40CE10}&noticeno=20260114-15&dt=01/14/2026&icount=15&totcount=42&flag=0
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: Settlement schedule revision affects shareholders tendering shares
  in the takeover offer but does not impact broader market operations
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20260114-15&attachedId=
processing:
  attempts: 1
  content_hash: ee467a02661425bf
  processed_at: '2026-01-14T15:46:25.143204'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2026-01-14T08:35:43+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={34C3BBE2-5F53-43FD-BB76-C4C5FD40CE10}&noticeno=20260114-15&dt=01/14/2026&icount=15&totcount=42&flag=0
severity: medium
source: bse
stocks:
- SHENTRACON
tags:
- takeover
- acquisition-window
- settlement-schedule
- revised-dates
- shentracon-chemicals
title: Revised Settlement Schedule for SHENTRACON CHEMICALS LIMITED Takeover Offer
---

## Summary

BSE has revised the settlement schedule for the Offer to Buy (Acquisition Window/Takeover) of SHENTRACON CHEMICALS LIMITED. The bid end date has been extended from January 23, 2026 to January 27, 2026, with corresponding changes to obligation download and settlement dates moved to February 9-10, 2026. This revision supersedes the original schedule announced in Notice No. 20260108-19.

## Key Points

- Bid period revised: January 12, 2026 to January 27, 2026 (extended from January 23)
- Settlement Number: 2026004
- Revised Obligation Download Date: February 9, 2026
- Revised Settlement Date: February 10, 2026
- Demat shares must be delivered only through Early Pay-in of Shares mechanism
- Market Type "Takeover" and settlement number 2026004 must be used in depository systems
- Client-wise stamp duty charges available in MBRSTD_OTB_CM_mmm_SettNo file

## Regulatory Changes

No new regulatory changes introduced. This circular implements a schedule revision within the existing framework for acquisition of shares through stock exchange as per SEBI guidelines.

## Compliance Requirements

- Members and Custodians must use Early Pay-in of Shares mechanism available in both depositories for demat share delivery
- Members/Custodians must specify Market Type "Takeover" and settlement number 2026004 in depository system entries
- Members must refer to Notice No. 20200528-32 dated May 28, 2020 for settlement guidelines under the revised mechanism for acquisition of shares
- Members should check MBRSTD_OTB_CM_mmm_SettNo file for client-wise stamp duty charges

## Important Dates

- **Bid Start Date**: January 12, 2026
- **Original Bid End Date**: January 23, 2026
- **Revised Bid End Date**: January 27, 2026
- **Revised Obligation Download Date**: February 9, 2026
- **Revised Settlement Date**: February 10, 2026
- **Notice Date**: January 14, 2026

## Impact Assessment

**Impact on Shareholders**: Shareholders of SHENTRACON CHEMICALS LIMITED who intend to tender their shares in the takeover offer now have an additional 4 days (until January 27) to participate. The settlement timeline has been extended by approximately 2 weeks.

**Impact on Members/Custodians**: Trading members and custodians handling tendered shares must adjust their operational schedules to accommodate the revised dates. They need to ensure proper usage of settlement number 2026004 and Market Type designation in their systems.

**Market Impact**: Limited broader market impact as this affects only a single company's takeover offer. The extension provides more time for shareholders to make informed decisions and complete tender formalities.

**Contact for Clarifications**: ICCL Help Desk at 022-69158590/45720490/45720690 or iccl.helpdesk@icclindia.com